Hirofumi Kai

机构：Kumamoto University · ORCID：0000-0001-9335-2424

发表论文 384 篇 · 总被引 6886 次 · h-index 43

代表论文

• The 2019 and 2021 International Workshops on Alport Syndrome (2022 · European Journal of Human Genetics · 被引 37)
• Metformin ameliorates the severity of experimental Alport syndrome (2021 · Scientific Reports · 被引 27)
• NanoLuc reporters identify COL4A5 nonsense mutations susceptible to drug-induced stop codon readthrough (2022 · iScience · 被引 21)
• Nitric oxide facilitates the targeting Kupffer cells of a nano-antioxidant for the treatment of NASH (2021 · Journal of Controlled Release · 被引 19)
• Activation of heat shock response improves biomarkers of NAFLD in patients with metabolic diseases (2021 · Endocrine Connections · 被引 18)
• Differential mode of cholesterol inclusion with 2‐hydroxypropyl‐cyclodextrins increases safety margin in treatment of Niemann‐Pick disease type C (2021 · British Journal of Pharmacology · 被引 17)